Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease
Recruiting
Phase 2
Interventional Study
Interstitial Lung Disease (ILD)
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 20 (estimated)
- Sponsor
- Region Skane · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Interstitial lung disease (ILD).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* The subject has given written consent to participate in the study
* Physician diagnosis of fibrosing ILD according to international guidelines
* age 18 years or older
* able to cycle
* able to understand and talk Swedish to participate in the study procedures, as judged by the…
Contacts